Berkshire Hathaway Takes New Stakes in UnitedHealth and Nucor, Sells Apple Shares
ByAinvest
Friday, Aug 15, 2025 7:13 am ET1min read
AAPL--
The Omaha-based conglomerate acquired a new stake in UnitedHealth during the second quarter of 2025, with the exact size of the stake not disclosed. The move comes as UnitedHealth faces a Justice Department investigation into its Medicare billing practices and a public backlash against rising healthcare costs. Despite these challenges, the insurer's stock saw a significant boost after the disclosure, indicating investor confidence in the company's future prospects.
Berkshire Hathaway also took a new stake in Nucor, the steel manufacturer, acquiring 6.61 million shares valued at $856.8 million. This investment is part of Berkshire's ongoing strategy to diversify its portfolio and invest in sectors that offer long-term growth potential.
Meanwhile, Berkshire Hathaway reduced its position in Apple by approximately 7%. The exact details of the reduction were not disclosed, but it is clear that the conglomerate is adjusting its portfolio to reflect changing market conditions and investment opportunities.
These moves come as Berkshire Hathaway prepares for a leadership transition. Warren Buffett, who will turn 95 this month, is stepping down as CEO at the end of the year, with Greg Abel taking over. Buffett will remain as chairman of the board.
References:
[1] https://www.cnbc.com/2025/08/14/warren-buffetts-berkshire-hathaway-unh.html
[2] https://seekingalpha.com/news/4485669-berkshire-hathaway-takes-new-stakes-in-unitedhealth-nucor-pares-back-on-apple
NUE--
UNH--
Berkshire Hathaway, led by Warren Buffett, has taken new stakes in UnitedHealth and Nucor, while reducing its position in Apple. UnitedHealth stock rose 8.2% in after-hours trading following the disclosure of Berkshire Hathaway's new stake in the health insurer. The exact size of the stake was not disclosed.
Berkshire Hathaway, led by Warren Buffett, has taken new stakes in UnitedHealth and Nucor, while reducing its position in Apple. UnitedHealth stock rose 8.2% in after-hours trading following the disclosure of Berkshire Hathaway's new stake in the health insurer.The Omaha-based conglomerate acquired a new stake in UnitedHealth during the second quarter of 2025, with the exact size of the stake not disclosed. The move comes as UnitedHealth faces a Justice Department investigation into its Medicare billing practices and a public backlash against rising healthcare costs. Despite these challenges, the insurer's stock saw a significant boost after the disclosure, indicating investor confidence in the company's future prospects.
Berkshire Hathaway also took a new stake in Nucor, the steel manufacturer, acquiring 6.61 million shares valued at $856.8 million. This investment is part of Berkshire's ongoing strategy to diversify its portfolio and invest in sectors that offer long-term growth potential.
Meanwhile, Berkshire Hathaway reduced its position in Apple by approximately 7%. The exact details of the reduction were not disclosed, but it is clear that the conglomerate is adjusting its portfolio to reflect changing market conditions and investment opportunities.
These moves come as Berkshire Hathaway prepares for a leadership transition. Warren Buffett, who will turn 95 this month, is stepping down as CEO at the end of the year, with Greg Abel taking over. Buffett will remain as chairman of the board.
References:
[1] https://www.cnbc.com/2025/08/14/warren-buffetts-berkshire-hathaway-unh.html
[2] https://seekingalpha.com/news/4485669-berkshire-hathaway-takes-new-stakes-in-unitedhealth-nucor-pares-back-on-apple

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet